FIA
VKTX icon

FNY Investment Advisers’s Viking Therapeutics VKTX Stock Holding History

FNY Investment Advisers’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
8,170
-934
-10% -$30.2K 0.11% 195
2026
Q1 		$296K Sell
9,104
-1,360
-13% -$43.7K 0.13% 164
2025
Q4 		$368K Sell
10,464
-1,164
-10% -$41.2K 0.1% 165
2025
Q3 		$305K Buy
11,628
+3,744
+47% +$112K 0.1% 213
2025
Q2 		$208K Buy
7,884
+1,834
+30% +$48.3K 0.09% 205
2025
Q1 		$146K Sell
6,050
-100
-2% -$3.16K 0.09% 174
2024
Q4 		$247K Sell
6,150
-5,825
-49% -$332K 0.13% 157
2024
Q3 		$758K Buy
11,975
+5,338
+80% +$313K 0.37% 76
2024
Q2 		$351K Buy
6,637
+1,387
+26% +$90.9K 0.24% 73
2024
Q1 		$430 Buy
+5,250
New +$234K 0.26% 77
2023
Q1 		– Sell
-40
Closed – – 751
2022
Q4 		$0 Sell
40
-140
-78% -$625 ﹤0.01% 772
2022
Q3 		$0 Hold
180
– – ﹤0.01% 867
2022
Q2 		$0 Hold
180
– – ﹤0.01% 929
2022
Q1 		$0 Hold
180
– – ﹤0.01% 924
2021
Q4 		$0 Hold
180
– – ﹤0.01% 827
2021
Q3 		$1K Hold
180
– – ﹤0.01% 658
2021
Q2 		$1K Hold
180
– – ﹤0.01% 733
2021
Q1 		$1K Sell
180
-40
-18% -$281 ﹤0.01% 728
2020
Q4 		$1K Hold
220
– – ﹤0.01% 731
2020
Q3 		$1K Hold
220
– – ﹤0.01% 444
2020
Q2 		$1K Hold
220
– – ﹤0.01% 391
2020
Q1 		$1K Hold
220
– – ﹤0.01% 409
2019
Q4 		$1K Sell
220
-5,000
-96% -$36.4K ﹤0.01% 770
2019
Q3 		$35K Hold
5,220
– – 0.01% 444
2019
Q2 		$43K Sell
5,220
-80
-2% -$684 0.01% 384
2019
Q1 		$52K Buy
5,300
+300
+6% +$2.51K 0.02% 331
2018
Q4 		$38K Sell
5,000
-14,500
-74% -$173K 0.01% 278
2018
Q3 		$339K Buy
19,500
+13,500
+225% +$161K 0.08% 143
2018
Q2 		$56K Buy
+6,000
New +$39.9K 0.02% 275

Other funds holding VKTX

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
LA
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
LAM
Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return

FNY Investment Advisers's VKTX Position: Q2 2026 in Review

FNY Investment Advisers reduced its Viking Therapeutics (VKTX) stake by 10% in Q2 2026, selling an estimated $30.2K and leaving 8,170 shares worth $318K. The position accounts for 0.11% of the portfolio, ranked #195.

FNY Investment Advisers first reported a position in VKTX in Q2 2018 and has held it in 29 quarters since. The position peaked at $758K in Q3 2024. 92 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • FNY Investment Advisers held 8,170 shares of Viking Therapeutics worth $318K as of Q2 2026.
  • FNY Investment Advisers sold 934 Viking Therapeutics shares in Q2 2026, an estimated $30.2K.
  • Viking Therapeutics made up 0.11% of FNY Investment Advisers's portfolio in Q2 2026, its #195 holding.
  • FNY Investment Advisers first reported a position in Viking Therapeutics in Q2 2018 and has held it in 29 quarters since.
  • FNY Investment Advisers's Viking Therapeutics position peaked at $758K in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.